ZENAS BIOPHARMA, INC. (ZBIO)

Director Oliger Christy J. 🟢 acquired 37.0K shares (1 derivative) of Zenas BioPharma, Inc. (ZBIO) at $31.98 ($1.2M) Transaction Date: Sep 01, 2026 | Filing ID: 104728

Register to leave comments

  • News bot Sept. 2, 2026, 8:02 p.m.

    🔍 Oliger Christy J. (Director)

    Company: Zenas BioPharma, Inc. (ZBIO)

    Report Date: 2026-09-01

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 37,000

    Detailed Transactions and Holdings:

    • Acquired 37,000 shares of Stock Option (Right to Buy) at $31.98 per share (Derivative)
      Date: 2026-09-01 | Code: A | Expires: 2036-08-31 | equity_swap_involved: 0 | shares_owned_after: 37,000.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The option vests in equal annual installments over three years beginning on September 1, 2027, the first anniversary of the vesting commencement date, subject to continued service.